Lead Optimization
Lead Optimization
Lead Optimization
1,250EGP
Contents:
- Complex Crystal Structure Analysis
- Receptor Mapping.
- Receptor Map Annotations for Optimization.
Learning Objectives:
- Identify the receptor hotspots for potential interaction with the ligand.
- Recognize the available spaces in the active site to utilize for the interaction with the ligand.
- Analyze the receptor mapping results efficiently.
Learning Outcomes:
- Making a decision on the pathways of ligand development to optimize the related profile.
- Discrimination between the PD-based and PK-based approaches for lead optimization.
Language: English-Arabic
Trainer: Associate Professor of Medicinal Chemistry & CEO-Founder of PROTAC Scientific – Drug Discovery Pro
- Associate Professor of Medicinal Chemistry & CEO-Founder of PROTAC Scientific - Drug Discovery Pro
Dr. Shaymaa Kassab’s specialty is in enhancing the inhibitory selectivity of traditional therapies against some isozymes implicated in critical disorders in order to reduce the negative effects of pan inhibition.
Dr. Kassab is working on significant initiatives aimed at developing selective COX-2 medications with minimum CVS problems and selective histone deacetylase inhibitors with minimal cytotoxic side effects. She just wrote a book chapter named “Indomethacin: From Anti-Inflammatory to Anticancer Agent” in the book ISBN 978-953-51-6985-7. She is now an official reviewer for the European Journal of Medicinal Chemistry; ACS Omega, Journal of Medicinal Chemistry, and Frontiers in Chemistry. Furthermore, she has made significant contributions to the adoption of laboratory-friendly reaction conditions and restricted chemical reaction steps to generate the designed novel candidates in such a way that pharmaceuticals may be synthesized and scaled.